Navigation Links
Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
Date:9/24/2007

WASHINGTON, Sept. 24 /PRNewswire-USNewswire/ -- Benjamin England, Special Counsel with Jones Walker, will testify before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, of the House Committee on Appropriations, on Tuesday, September 25, 2007 at 10:00 a.m. in Room 2362A of the Rayburn House Office Building. His testimony will focus on the on the Food & Drug Administration's (FDA) Import Strategic Plan that relates to the import of food, drugs and products from other countries, principally China.

Mr. England spent 17 years with the FDA, his last three years as Regulatory Counsel to the Associate Commissioner for Regulatory Affairs. He is the co-author of the FDA Import Strategic Plan, the foundational document for the FDA's current Strategic Framework and Action Plan.

Mr. England is available to the news media to discuss his testimony, and the areas of:

-- Current issues related to the import of toys, food, and

pharmaceuticals from China and other countries

-- Measurable solutions to the current FDA import crisis

-- Implications of FDA reorganization and the single food agency

proposals

-- Legislative proposals intended to reinforce the FDA's import

inspection process

-- Risk management applied by industry to the benefit of consumers

-- FDA regulatory compliance and enforcement and inspections issues

-- The intersection of Customs, FDA and other border agency

jurisdictions, programs, and policies

-- Consumer protection issues

Mr. England can be reached by contacting Debra Colbert, 301-565-5329, daccomm@aol.com; cell: 301-332-0813

Jones Walker, with more than 200 attorneys, provides the full range of legal services to a national and international corporate client base through offices in Florida, Louisiana, Texas, and Washington, D.C. For more information, visit

SOURCE Jones Walker
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Former smokers can be protected with vitamin A derivative
2. Reliable Help For Smokers From Nicotine Patches and Former Smokers
3. Former IMO President Shows Interest In Winning General Election
4. Former FDA Commissioner Accused in Criminal Case
5. Justice To Former Male Nurse In sex Discrimination Case
6. Residents Of Former Industrial Towns In UK Most likely To Become Obese
7. Sex Determination Test Informers to be Rewarded
8. Former Malaysian Prime Minister Suffers Heart Attack
9. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
10. Former Chilean Dictator Hospitalised After Heart Attack
11. Former Chilean Dictator Recovering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TORONTOandCALGARY,Nov.25/PRNewswire/-SentinelleMed...aging(MRI)coilsandsoftwareandCalgaryScientificInc....veintroducedawebversionofAegis(TM)Breast4DAdvanced...ceisthefirsttrulyzero-footprintWebclientbasedmedic...reWeb(TM)platformallowsforzero-footprintaccess-req...
(Date:11/25/2009)...SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQual...ter Spare the Air Alert forThursday,...relogsoranyothersolidfuel,bothindoorsandoutdoors. ...irqualitytomorrow,"saidJackBroadbent,executiveoffi...respectthehealthoftheirneighborsandfellowcommunity...
(Date:11/25/2009)...tress increase blood pressure? This simple questi... years. New Stress-related gene Modulates High Bl...blood pressure? This simple question has been the...w research has for the first time established a li...pressure response to stress in mice as well as hum...
(Date:11/25/2009)...s often plagued by neurological symptoms, study fi...ews) -- Neurological side effects are among the po...esticular cancer who were treated with cisplatin-b... study included 1,409 Norwegian men treated for un...ho took part in a follow-up survey conducted from ...
(Date:11/25/2009)...DGE, Mass. -- A cancer vaccine carried into the bo...lant is the first to successfully eliminate tumors...urnal Science Translational Medicine . , The ne...gists at Harvard University, uses plastic disks im...ed under the skin to reprogram the mammalian immun...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... for 86% of Florida,s Medicar... The Quantum Group,Inc. (Amex: QGP ), a Wellingto... today Quantum subsidiary Renaissance Health Syste...ent 86%,of Florida,s Medicare population., Noel J...
...s More Virulent 027 Strain ... Cepheid (Nasdaq:,CPHD) today announced the relea...Mark product under the European Directive on In Vi...ultaneously,detects and identifies the commonly oc...
...Money and Awareness for ...0 Hundreds of families,joined hosts Jenny McCarth...pot.com ( http://www.totspot.com ) at The Treehous...king site for,babies, toddlers, and kids -- and of...
... Nov. 9-15, DENVER, Nov. 10 Students at Peakview... country can bring their beloved teddy,bears and o...ing room,nurses will sew, button and bandage them ... (AORN),Perioperative Nurse Week (http://www.aorn...
...dent of,the American Veterinary Medical Associatio...tion -- treating pets that have become sick due to...ristmas and into New Years, we,ll see it,every yea... but people need to focus on keeping their pets,he...
...ifies potential savings of $6 million in early ten...hington, DC (PRWEB) November 10, 2008 -- Infohrm ...ng and analytics solutions, today released a case ...workforce data, WellPoint is on track to save over...
Other Medicine News:Health News:The Quantum Group Inc. Announces Expansion into Three Florida Counties 2Health News:The Quantum Group Inc. Announces Expansion into Three Florida Counties 3Health News:Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 2Health News:Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 3Health News:Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market 4Health News:TotSpot.com Celebrates Launch With Jenny McCarthy, Joely Fisher, Tori Spelling and Other Celebrity Mommies at The Treehouse Social Club 2Health News:Teddy Bear Hospital Helps Ease Kids' Anxieties About Surgery 2Health News:AVMA's Top Ten List on Holiday Pet Health 2Health News:Infohrm Member Client Saves Millions of Dollars Through Workforce Analytics 2Health News:Infohrm Member Client Saves Millions of Dollars Through Workforce Analytics 3
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, IntranasalDrugDelivery-USMarketTrend...67/Intranasal-Drug-Delivery---US-Market-Trends--An...etiswitnessinganexpansionoftherapeuticapplications...tothedeliveryofsystemictherapeuticdrugs.Thefutureo...
(Date:11/25/2009)...OUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCent...fromtheCompany,sPROTECT-1(theProspectiveRandomized...cet-EN(TM)(CCX282-B)inpatientswithmoderate-to-seve...avorablesafetyandtolerabilityprofile.Thestudydemon...iseaseseverityasdefinedasa70-pointdecreaseintheCro...
(Date:11/24/2009)...RVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endolog...etreatmentsforaorticdisorders,announcedtodaythatit...n,thepatentinfringementlawsuitbroughtagainstitinOc...atesDistrictCourtinIndianapolis,Indiana. ,, End...eUnitedStatesPatentandTrademarkOffice(USPTO)conduc...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 1ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 8ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 1ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 3ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 4ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 5ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 6ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 7
...ril 23, 2007 /PRNewswire/ -- Sirion Therapeutics,a...ipeline,compounds, ST-601 (difluprednate) and ST-6...nual meeting of The Association for,Research in Vi...L.,In addition to these presentations, the company... ST-601 (difluprednate) is currently being evaluat...
...alyses To Be Presented --, SAN FRANCISCO, April 24...today announced that data from the Company,s Phase...sease will be,presented for the first time in the ...,s 59th Annual Meeting in Boston on Thursday,May ...l include new,data from both the mild and moderate...
Other Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3
Qwik-Let® Premier
Finnpipette Techpette Single Channel, 5-50ul
...he range from 2ul to 5000ul. Fills and empties th...advertent volume change. Novel hand grip shape re...lavable at 121C(250F). To prevent corrosion the t...-handed operation. Auto or Normal trigger mode. ...
...om Thermo Labsystems was designed specifically to .... Advanced features such as the new fast dial sys...mes help to define this as a new leader in single ...late offers a custom fit for different hand sizes....
Medicine Products: